Hansen, Morten, Kristine Hare, Jens Holst, and Filip Knop
PubMed Randomized trialSemaglutide evidence2021 Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response
Begin Your Weight Loss Journey in Lafayette Today MinuteMed Walk-In Clinic is proud to serve the Lafayette, Louisiana community with a medical weight loss program that combines professional care, nutrition support, and GLP-1 Injectables
Tirzepatide exerts its therapeutic effects through dual agonism of two key incretin receptors: the GIPR and the GLP-1R
These effects were generally mild to moderate in intensity and were most frequent during the dose escalation period, becoming less common as participants remained on their maintenance dose